Novotalk, Ltd. – Trademark Portfolio

Entity Type: 99

Novotalk, Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NOVOTALK. The owner is based in Bnei Brak.

86 Rabbi Akiva St., 8th floor

Bnei Brak 5144004 , IL

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #88136469
Registered 2018
NOVOTALK
NOVOTALK
Registered 2018

Trademark Classifications

Novotalk, Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Novotalk, Ltd. have?

Novotalk, Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Novotalk, Ltd. file in?

Novotalk, Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Novotalk, Ltd.'s most well-known trademarks?

Novotalk, Ltd.'s registered trademark portfolio includes well-known marks such as NOVOTALK. These are among 2 currently registered trademarks in the portfolio.

What is Novotalk, Ltd.'s trademark registration success rate?

Novotalk, Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.